Relatlimab
Relatlimab (BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM) . Relatlimab is often used with Nivoluma to treat advanced melanoma.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1673516-98-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LMF550Hu 96 Tests
Multiplex Assay Kit for Lamin A/C (LMNA), etc. by FLIA (Flow Luminescence Immunoassay)
Ask
View Details 
QP5703-ec-100ug 100ug
Recombinant Human BAG family molecular chaperone regulator 2 Protein, GST, E.coli-100ug
Ask
View Details